<p>High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant <em>Acinetobacter baumannii</em> in Intensive Care Unit</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit

Published:2020-05 Issue: Volume:Volume 13 Page:1447-1454
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Bai Xiang-Rong,Jiang De-Chun,Yan Su-Ying

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference47 articles.

1. Ventilator-associated pneumonia in the ICU

2. Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis

3. Ventilator associated pneumonia in a medical intensive care unit: Microbial aetiology, susceptibility patterns of isolated microorganisms and outcome

4. Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

5. Task force on management and prevention of Acinetobacter baumannii infections in the ICU

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to Guide Empiric Antibiotic Treatment for Ventilator-Associated Pneumonia in a Mexican Tertiary Care University Hospital;2024-08-20

2. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia;Critical Reviews in Microbiology;2024-07

3. Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection;Biomedical Reports;2023-06-13

4. Clinical Efficacy, Antibiotic Resistance Genes, Virulence Factors and Outcome of Hospital-Acquired Pneumonia Induced by Klebsiella pneumoniae Carbapenemase 2-Producing with Tigecycline Treatment in the ICU;Infection and Drug Resistance;2022-09

5. Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective;Expert Review of Anti-infective Therapy;2022-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3